Drug Pipeline

Low Sodium Oxybate Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-04 NCT07625280 A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in… Phase 3 Not Yet Recruiting
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05837091 Low Sodium Oxybate in Patients With Idiopathic Hypersomnia Idiopathic Hypersomnia Recruiting
Phase 3
NCT07625280 A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in… Narcolepsy Not Yet Recruiting
Phase 2
NCT06421532 Stimulating Amyloid Clearance in Cerebral Amyloid Angiopathy Cerebral Amyloid Angiopathy Enrolling by Invitation
Sponsors Running Low Sodium Oxybate Trials
Mayo Clinic (1) Leiden University Medical Center (1) Jazz Pharmaceuticals (1)
Get alerts when Low Sodium Oxybate trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free